3.1 Sponsored satellite session: Test and treat strategies as catalysts for strengthening research capacity and pandemic preparedness

Session detail

Organiser: Emergent BioSolutions, USA

This session promises to deliver cutting-edge insights into how diagnostics can serve as a cornerstone for strengthening Africa’s research environment while advancing global pandemic preparedness efforts.

Objectives

  1. Capacity Building: Highlight how investments in diagnostics can strengthen research infrastructure and scientific leadership in LMICs.
  2. Innovation: Showcase cutting-edge diagnostic technologies that have transformed outbreak response capabilities.
  3. Equity: Address barriers to equitable access to diagnostics and propose sustainable solutions.
  4. Collaboration: Foster partnerships between academia, industry, governments, and global health organisations to enhance pandemic preparedness.

Expected Outcomes

  • A roadmap for integrating diagnostics into pandemic preparedness frameworks.
  • Recommendations for strengthening local manufacturing of diagnostic tools
  • Identification of opportunities for interdisciplinary training and capacity building.
  • Strategies for fostering equitable North-South partnerships to sustain research ecosystems.

 

The MOSA study: Advancing Mpox Therapeutics and Research Capacity

Speakers:
  • Placide Mbala, National Institute of Biomedical Research, Democratic Republic of Congo

Global Research Partnerships: Strengthening Diagnostic Ecosystems in Africa

Speakers:
  • Duduzile Ndwandwe, Cochrane South Africa & GloPID-R Africa Hub Secretariat, South Africa

Industry’s Role in Building Infrastructure of Pandemic Preparedness

Speakers:
  • Kevin Yeo, Emergent BioSolutions, United Kingdom